Detalhe da pesquisa
1.
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
Proc Natl Acad Sci U S A
; 120(45): e2307094120, 2023 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922327
2.
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1ß.
Proc Natl Acad Sci U S A
; 118(21)2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016751
3.
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
Proc Natl Acad Sci U S A
; 117(22): 12324-12331, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409605
4.
MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
Cancer Metastasis Rev
; 39(3): 769-781, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410111
5.
Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein.
Int J Mol Sci
; 23(1)2021 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008495
6.
MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
Pharmacol Res
; 155: 104695, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32061839
7.
STAT3- and GSK3ß-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Carcinogenesis
; 40(1): 173-183, 2019 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395230
8.
Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Mol Cancer Ther
; 22(10): 1115-1127, 2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721536
9.
Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935566
10.
Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter.
Cancers (Basel)
; 14(6)2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326649
11.
Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor.
Front Oncol
; 12: 812560, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35402258
12.
Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging.
Cancers (Basel)
; 13(4)2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670594
13.
SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
Life Sci
; 287: 120141, 2021 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774620
14.
Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Mol Cancer Ther
; 18(11): 1997-2007, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345950
15.
Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer.
Adv Cancer Res
; 137: 37-75, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29405977
16.
Good's buffer derived highly emissive carbon quantum dots: excellent biocompatible anticancer drug carrier.
J Mater Chem B
; 4(14): 2412-2420, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32263191
17.
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Oncotarget
; 6(18): 16623-37, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26009874
18.
Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway.
PLoS One
; 9(6): e100228, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972086